878 related articles for article (PubMed ID: 34114269)
1. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
[TBL] [Abstract][Full Text] [Related]
2. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
Dang YL; Bryson A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
Kanabar G; Wilkinson P
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
[TBL] [Abstract][Full Text] [Related]
4. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Oo WM; Giri P; de Souza A
J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
[TBL] [Abstract][Full Text] [Related]
5. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine.
Maramattom BV; Krishnan P; Paul R; Padmanabhan S; Cherukudal Vishnu Nampoothiri S; Syed AA; Mangat HS
Ann Neurol; 2021 Aug; 90(2):312-314. PubMed ID: 34114256
[TBL] [Abstract][Full Text] [Related]
7. Bilateral facial palsy after COVID-19 vaccination.
Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome after COVID-19 vaccination.
McKean N; Chircop C
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
[TBL] [Abstract][Full Text] [Related]
10. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
Sii HL; Ng SH; Wong VF; Law WC
Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
[TBL] [Abstract][Full Text] [Related]
14. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review.
Liang H; Cao Y; Zhong W; Ma Z; Liu J; Chen H
Hum Vaccin Immunother; 2022 Nov; 18(6):2125753. PubMed ID: 36315834
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
Leung C
Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
[TBL] [Abstract][Full Text] [Related]
16. The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan.
Su SC; Lyu RK; Chang CW; Tseng WJ
Acta Neurol Taiwan; 2022 Jan; 31(1)():46-51. PubMed ID: 34988954
[TBL] [Abstract][Full Text] [Related]
17. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY
J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410
[TBL] [Abstract][Full Text] [Related]
18. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
